Let's Talk... SMA at EPNS 2022

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Apr 29 / Springer Healthcare

Let's Talk... SMA at EPNS 2022

Neuroscience Spinal Muscular Atrophy EPNS-2022

Description

In the first part of this episode, we talk to Laurent Servais about the challenges in treatment decision making for spinal muscular atrophy and how they could be addressed.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.